- Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
[作者:Eisen, T; Oudard, S; Szczylik, C; Gravis, G; Heinzer, H; Middleton, R; Cihon, F; Anderson, S; Shah, S; Bukowski, R; Escudier, B,期刊:Journal of the National Cancer Institute, 页码:1454-1463 , 文章类型: Article,,卷期:2008年100-20]
- Background The perception that older cancer patients may be at higher risk than younger patients of toxic effects from cancer therapy but may obtain less clinical benefit from it may be based on the underrepresentation o...
- A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion
[作者:Stathopoulos, GT; Psallidas, I; Moustaki, A; Moschos, C; Kollintza, A; Karabela, S; Porfyridis, I; Vassiliou, S; Karatza, M; Zhou, ZM; Joo, M; Blackwell, TS; Roussos, C; Graf, D; Kalomenidis, I,期刊:Journal of the National Cancer Institute, 页码:1464-1476 , 文章类型: Article,,卷期:2008年100-20]
- Background Tumor cells in malignant pleural effusions (MPEs) are an important source of monocyte chemoattractant protein (MCP)-1. However, the role of tumor-derived MCP-1 in the pathogenesis and progression of MPE has no...
- Prospective Evaluation of Risk Factors for Male Breast Cancer
[作者:Brinton, LA; Richesson, DA; Gierach, GL; Lacey, JV; Park, Y; Hollenbeck, AR; Schatzkin, A,期刊:Journal of the National Cancer Institute, 页码:1477-U9 , 文章类型: Article,,卷期:2008年100-20]
- Most risk factors for male breast cancer have been derived from retrospective studies that may reflect selective recall. In the prospective National Institutes of Health AARP Diet and Health Study, we studied 324 920 men...
|